To the best of our knowledge, our study is the first to analyze in detail the associations between the CDKN1B and CCND2 gene polymorphic variants and the time to CLL progression reflected in lymph node and organ progression, treatment onset, or progression to a higher Rai stage. The gene discussed is CCND2; the disease is B-cell chronic lymphocytic leukemia.